BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

634 related articles for article (PubMed ID: 9111866)

  • 21. Deregulated expression of cell-cycle proteins during premalignant progression in SENCAR mouse skin.
    Rodriguez-Puebla ML; LaCava M; Gimenez-Conti IB; Johnson DG; Conti CJ
    Oncogene; 1998 Oct; 17(17):2251-8. PubMed ID: 9811455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transforming growth factor-beta-mediated p15(INK4B) induction and growth inhibition in astrocytes is SMAD3-dependent and a pathway prominently altered in human glioma cell lines.
    Rich JN; Zhang M; Datto MB; Bigner DD; Wang XF
    J Biol Chem; 1999 Dec; 274(49):35053-8. PubMed ID: 10574984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell cycle and transcriptional control of human myeloid leukemic cells by transforming growth factor beta.
    Hu X; Zuckerman KS
    Leuk Lymphoma; 2000 Jul; 38(3-4):235-46. PubMed ID: 10830731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TGF-beta1-induced cell cycle arrest in renal mesangial cells involves inhibition of cyclin E-cdk 2 activation and retinoblastoma protein phosphorylation.
    Schoecklmann HO; Rupprecht HD; Zauner I; Sterzel RB
    Kidney Int; 1997 Apr; 51(4):1228-36. PubMed ID: 9083291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL; Buffolino P; Kopman C; Nathanson L
    Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-malignant and tumor-derived cells differ in their requirement for p27Kip1 in transforming growth factor-beta-mediated G1 arrest.
    Donovan JC; Rothenstein JM; Slingerland JM
    J Biol Chem; 2002 Nov; 277(44):41686-92. PubMed ID: 12202478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential control of cyclins D1 and D3 and the cdk inhibitor p27Kip1 by diverse signalling pathways in Swiss 3T3 cells.
    Mann DJ; Higgins T; Jones NC; Rozengurt E
    Oncogene; 1997 Apr; 14(15):1759-66. PubMed ID: 9150381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1).
    Depoortere F; Pirson I; Bartek J; Dumont JE; Roger PP
    Mol Biol Cell; 2000 Mar; 11(3):1061-76. PubMed ID: 10712520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypo-phosphorylation of the retinoblastoma protein (pRb) by cyclin D:Cdk4/6 complexes results in active pRb.
    Ezhevsky SA; Nagahara H; Vocero-Akbani AM; Gius DR; Wei MC; Dowdy SF
    Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10699-704. PubMed ID: 9380698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of expression and activity of distinct pRB, E2F, D-type cyclin, and CKI family members during terminal differentiation of P19 cells.
    Gill RM; Slack R; Kiess M; Hamel PA
    Exp Cell Res; 1998 Oct; 244(1):157-70. PubMed ID: 9770359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. E2F-1 overexpression in cardiomyocytes induces downregulation of p21CIP1 and p27KIP1 and release of active cyclin-dependent kinases in the presence of insulin-like growth factor I.
    von Harsdorf R; Hauck L; Mehrhof F; Wegenka U; Cardoso MC; Dietz R
    Circ Res; 1999 Jul; 85(2):128-36. PubMed ID: 10417394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells.
    Guo Y; Kyprianou N
    Cell Growth Differ; 1998 Feb; 9(2):185-93. PubMed ID: 9486855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The viral oncoprotein E1A blocks transforming growth factor beta-mediated induction of p21/WAF1/Cip1 and p15/INK4B.
    Datto MB; Hu PP; Kowalik TF; Yingling J; Wang XF
    Mol Cell Biol; 1997 Apr; 17(4):2030-7. PubMed ID: 9121451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p27Kip1: a key mediator of retinoic acid induced growth arrest in the SMS-KCNR human neuroblastoma cell line.
    Matsuo T; Thiele CJ
    Oncogene; 1998 Jun; 16(25):3337-43. PubMed ID: 9681834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p21Cip1 and p27Kip1 act in synergy to alter the sensitivity of naive T cells to TGF-beta-mediated G1 arrest through modulation of IL-2 responsiveness.
    Wolfraim LA; Walz TM; James Z; Fernandez T; Letterio JJ
    J Immunol; 2004 Sep; 173(5):3093-102. PubMed ID: 15322169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myc downregulation by transforming growth factor beta required for activation of the p15(Ink4b) G(1) arrest pathway.
    Warner BJ; Blain SW; Seoane J; Massagué J
    Mol Cell Biol; 1999 Sep; 19(9):5913-22. PubMed ID: 10454538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of p27Kip1 in G1 arrest by high dose 5 alpha-dihydrotestosterone in LNCaP human prostate cancer cells.
    Tsihlias J; Zhang W; Bhattacharya N; Flanagan M; Klotz L; Slingerland J
    Oncogene; 2000 Feb; 19(5):670-9. PubMed ID: 10698512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of cyclin A and p27 in anti-IgM induced G1 growth arrest of murine B-cell lymphomas.
    Ezhevsky SA; Toyoshima H; Hunter T; Scott DW
    Mol Biol Cell; 1996 Apr; 7(4):553-64. PubMed ID: 8730099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cdk inhibiting proteins].
    Tomoda K; Kato J
    Gan To Kagaku Ryoho; 1997 Sep; 24(11):1407-13. PubMed ID: 9309133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1.
    Korkolopoulou P; Christodoulou P; Konstantinidou AE; Thomas-Tsagli E; Kapralos P; Davaris P
    Hum Pathol; 2000 Jun; 31(6):751-60. PubMed ID: 10872671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.